For more than 20 years the Pediatric Diabetes Research Group at the University of Iowa has studied pediatric Type 1 diabetes, and more recently Type 2 diabetes and Cystic Fibrosis-Related Diabetes with clinical studies and trials.
Pivotal studies on continuous glucose monitoring, on prevention of diabetes in relatives of type 1 diabetes patients, on immune modulation of new onset Type 1 diabetes have been performed as part of consortiums funded federally or from foundations such as the Juvenile Diabetes Research Foundation and the Helmsley Foundation. In addition, the group has been part of a five clinical center NIH funded consortium studying hypoglycemia prevention in Type 1 diabetes and most recently performed neuroanatomical and neurocognitive studies evaluating the effect of hyper and hypoglycemia on the developing brain of young children with Type 1 diabetes. Findings have been original and unprecedented in literature. See here and here.
Clinical trials conducted by the group in adolescents with Type 2 diabetes have led to identifying appropriate pharmacologic approaches for this recently common adolescent disease.
In recent years, Dr. Katie Larson-Ode has joined the group and her studies have identified abnormal glucose metabolism in young children with Cystic Fibrosis. This finding has led to multiple clinical studies with impactful outcomes and funding by the Cystic Fibrosis Foundation for a multicenter consortium to conduct pivotal studies in these young children. Dr. Larson Ode and the Pediatric Diabetes Research Group are one of the clinical centers and the coordinating center for the consortium.
If you think you may have a patient that qualifies to participate in a study, or if you just want to find out more, feel free to contact Joanne Cabbage or email the group at firstname.lastname@example.org.
- Investigators: Eva Tsalikian, Michael Tansey, Katie Larson Ode
- Research Coordinator: Julie Coffey, ARNP
- Research Assistants: Joanne Cabbage, Rachel Bisbee, Marissa Goetz